The warning states that in animal studies, semaglutide causes thyroid C-cell tumors
Most of the available research has focused on semaglutides use in type 2 diabetes and obesity, rather than conditions like Cushings syndrome
In August 2025 , the FDA approved Wegovy for another use: to treat a type of fatty liver disease called metabolic dysfunction-associated steatohepatitis (MASH) in adults who have moderate to advanced liver scarring (fibrosis) but do not have permanent liver damage (cirrhosis)
Actually, its more accurate to say because of limited supply , patients HAVE been able to obtain what they want
If you use sterile water, you should ideally use the entire vial in a single administration to avoid contamination
Some patients explore microdosing tirzepatide as a strategy for managing side effects or extending vial duration